成立时间 01
2022 [CO001] 尽调报告
Collaborative Robotics
实用型协作机器人已初步落地，经营披露仍有限
Collaborative Robotics 已显出早期实用型机器人平台的可信度，但经济性和客户规模仍不透明，现阶段还不足以支持激进下注。
覆盖范围与披露说明
公开报道足以确认创始人背景、融资、办公室扩张和早期现场部署；收入、现金消耗及合同经济性仍未披露。估值依据仍是二级市场信号，而非新一轮融资定价。
封面要素
公司概况
Collaborative Robotics 由 Brad Porter 于 2022 年在 Santa Clara 创立，开发用于共享空间和物料搬运的实用型协作机器人。公开报道显示，产品已在物流场景初步落地，团队也在 Seattle 扩张 AI 业务；General Catalyst 领投，多家投资机构参与。收入、烧钱速度和客户集中度仍不透明。
- 成立时间
- 2022-01-01
- 创始人
- Brad Porter
- 创立地点
- Santa Clara, California, USA
- 总部
- Santa Clara, California, USA
- 产品
- 面向共享空间的实用型协作机器人，重点服务物流和物料搬运工作流。
- 客户
- 物流、制造业、医疗健康、零售/电商以及部分公共服务场景。
- 商业模式
- 未披露。收入可能来自机器人销售、部署服务和支持软件；公司先从试点做起，再拓展部署规模。
- 阶段
- Series B
- 融资情况
- 2024 年完成 $100M Series B 融资；累计披露融资金额超过 $140M。
执行摘要
主要优势
- Brad Porter 的 Amazon 机器人履历扎实，为创始人与市场契合度提供有力背书。
- General Catalyst、Sequoia、Khosla 等知名机构及多家战略投资者参与支持。
- 物流场景已有早期现场部署，不只是实验室展示。
- 定位明确：聚焦实用型协作机器人，不追逐人形机器人热潮。
- 布局基础模型 AI 人才，为后续技术路线提供了合理想象空间。
主要风险
- 收入、烧钱速度和毛利率均未披露。
- 客户集中度与商业化可复制性仍不明朗。
- 人机共处场景下的安全与可靠性仍是核心技术风险。
- 硬件扩张需要大量资本，后续融资将持续承压。
- 相邻机器人赛道和自动化替代方案带来强劲竞争压力。
未决问题
- 经审计的收入与烧钱数据不可得。
- 具体客户名单、合同条款与部署站点数量均未披露。
- 公开渠道缺乏最新估值数据。
- 尚无关于设备运行时间和操作表现的技术基准数据。
目录
01公司概况
1.1 公司定位与领导团队
Collaborative Robotics 总部位于 Santa Clara，自称要造的是实用型协作机器人，而不是人形机器人展示品。Brad Porter 的 Amazon 机器人履历是创始人与市场契合度最有力的信号，也解释了公司为何能同时吸引战略投资者和综合型机构。公开资料还显示，团队规模不大，已在 Seattle 扩张 AI 业务，并聘请 Teresa Carlson 担任顾问。整体看，公司处于商业化早期，技术和投资人背书都不弱；但披露不足，尚不能按成熟运营企业承销。[CO001, CO002, CO003, CO004, CO007, CO009]
| 人员 | 职务 | 背景经历 | 是否创始人 | 关键人依赖度 |
|---|---|---|---|---|
| Brad Porter | CEO 兼创始人 | 前 Amazon Robotics 副总裁兼 Distinguished Engineer | 是 | 极高 |
| Teresa Carlson | 顾问 | 前 Amazon / Microsoft 公共部门业务负责人 | 否 | 中 |
| Michael Vogelsong | 基础模型 AI 负责人 | Amazon Deep Learning Technologies 联合创始人 | 否 | 中 |
| Alfred Lin | 董事会成员 | Sequoia 合伙人，曾任董事会主席 | 否 | 中 |
| Paul Kwan | 董事会成员 | General Catalyst 董事总经理，新加入董事会 | 否 | 中 |
部分公开领导团队架构；董事会及顾问角色基于已披露报道梳理。
[CO002, CO006, CO007]1.2 融资历程与运营规模
公司 2023 年完成 $30 million Series A，2024 年 4 月完成 $100 million Series B，披露融资累计超过 $140 million。General Catalyst 领投 B 轮，众多投资者继续加码。硬件机器人若没有一定现场进展，通常很难同时获得战略和财务投资人的支持。GeekWire 报道，公司团队约 40 人，规模仍小于其目标，并新开了 Seattle 办公室。这些迹象说明团队已在推进业务，但不足以证明公司已形成规模化制造或收入引擎。[CO004, CO005, CO006, CO010]
| 指标 | 数值 / 状态 | 日期 | 置信度 | 信息缺口 |
|---|---|---|---|---|
| 成立时间 | 2022 | 2022 | 高 | 具体月份未公开 |
| 总部 | Santa Clara, CA | 2024-2026 | 高 | |
| 员工数 | ~40 | 2024 | 中 | 到 2026 年员工数可能更高 |
| Series B | $100M | Apr 2024 | 高 | |
| 累计融资 | >$140M | Apr 2024 | 高 | 无官方股权结构表 |
| 当前估值 | 信息不透明 / 仅有二级市场估值信号 | 2024-2026 | 中 | 需审慎参考外部估算数据 |
| 主要创始人 | Brad Porter | 2022-2026 | 高 | |
| 已知顾问 | Teresa Carlson | 2024 | 中 | 公开顾问名单不完整 |
仅收录公开事实；估值与员工规模为二级市场与第三方估算。
[CO001, CO004, CO005, CO007, CO008]| 利益相关方 | 角色 | 重要程度 | 尽调重点关注问题 |
|---|---|---|---|
| General Catalyst | Series B 领投方 | 高 | 预留了多少后续跟投支持资金？ |
| Sequoia Capital | 董事会成员 / 主要投资方 | 高 | 下一轮融资的关键里程碑门槛是什么？ |
| Khosla Ventures | 战略性 VC 投资方 | 中 | 当前提供了多少技术商业化的实质支持？ |
| Mayo Clinic | 战略投资方 / 试点应用生态 | 中 | 验证了哪些具体的客户价值？ |
| Lux Capital | AI / 机器人专业投资方 | 中 | 重点跟踪哪些技术里程碑？ |
| Neo / 1984 / MVP / Calibrate | Seed 轮与 Series A 轮投资方 | 中 | 早期轮次的股权集中度如何？ |
利益相关方图谱系基于公开信号梳理，而非实际股权结构表重构。
[CO005, CO006]1.3 里程碑与未决缺口
关键进展不是一次产品发布，而是公司从 2022 年成立，到 2024 年首批机器人进入现场，再到不久后公开扩充 Seattle AI 团队。这说明公司已走出纯研发阶段；但公开收入、确切客户数和当前估值仍是尽调缺口。二级市场信息对这些数字的披露不充分或已过时，因此估值推算只能作粗略参照，不能当作承销锚点。整体来看，公司仍是早期机器人平台：融资能力有支撑，运营规模有限，信息披露也不充分。[CO008, CO011, CO012]
梳理公司成立、首批机器人现场部署和 Seattle AI 团队扩张等关键进展。
[CO001, CO005, CO010, CO007]02市场分析
2.1 市场界定
与其把 Collaborative Robotics 看作通用工业机器人公司，不如把它放在人机共处空间自动化这一类：机器人要贴近人员运行，同时搬运物料、协调任务。公司官网和 co.bot 品牌强调行为可预测、能用于真实场景；外部资料则将其归为移动操作机器人（mobile manipulation）和协作机器人（cobot）。买方买的不只是一条机械臂，还要一套能适配现有安全规范、场地和用工安排的工作流系统。落地难点不仅在技术，也在设施改造和赢得操作人员信任。[CM001, CM004, CM009, CM010]
2.2 买方画像与采用逻辑
早期买方很可能是物流或制造业运营商：重复搬运任务多、用工压力大，也有能力按流程跑试点。公开报道反复提及仓库、制造车间、医疗、零售和服务场景，这些地方都在意减轻体力负担、提高吞吐量。商业逻辑在于省人、改善人机工效、提升吞吐，而不是单为追求自主化而下注。若公司能突围，靠的是机器人能让具体工作流比纯人工更省钱或更可靠。长期市场逻辑还要证明，机器人可以标准化部署，不必每笔销售都变成定制集成项目。[CM002, CM006, CM007, CM010]
2.3 采用受限的深层原因
存量设施改造中的安全与集成仍是客户采用的最大阻力。共享空间机器人既要适应人员近距离作业，也要重排工作流、赢得操作人员信任。任务可以简化时，不少买方更愿意选固定式自动化或 AMR。协作机器人品类虽在增长，不代表销售容易。尽调要看 Collaborative Robotics 能否把行业顺风转成可复制部署，并拿出足够的 ROI 证据克服运营阻力。做得到，公司有望受益于以人为本的自动化趋势；做不到，可服务市场就会迅速收窄。[CM003, CM005, CM008, CM011, CM012]
以方向性区间呈现协作机器人落地的经济性及买方 ROI 门槛。
各层宽度仅表示层级，不代表数值比例。
[CM003, CM005, CM006]03竞争格局
3.1 直接竞争对手
竞争对手不止来自一个品类。公开资料显示，人形机器人初创公司、移动操作平台和传统仓储自动化厂商都在争夺同一批客户预算。Collaborative Robotics 不仅要面对外形相似的同行，也要和成本更低、成熟度更高的替代方案竞争；后者能用更窄的方案解决同一工作流。产品定位必须说清楚：如果机器人能在人类工作环境中作业、但不做人形，公司就得解释它为何胜过人形机器人，也胜过更简单的 AMR 工作流。赛道拥挤，定位含糊往往会变成价格问题。[CP001, CP002, CP003, CP006, CP009]
3.2 护城河与就绪度
更可能构成防线的不是专利墙，而是部署积累带来的学习效应：工作流接得更深、客户更信任，实际运营数据也更难被小型竞品复制。公开资料还看不到可对标的装机规模或性能榜单，因此护城河目前只是推测，尚未得到验证。若公司能胜出，可能凭的是其实用系统在真实场地更容易部署，而非像人形竞品那样吸睛。关键要看现场学习和集成深度，不是品牌声量。[CP004, CP005, CP007, CP010, CP011]
3.3 竞争维度的启示
市场机会真实，但赛道足够拥挤，执行稍弱就可能抹平先发优势。公司要拿出可复制的部署，而不只是一个巧妙的机器人概念；还要证明非人形定位是优势，不是妥协。品类尚无公认赢家，一旦有公司显现出更清晰的产品市场契合度，份额可能迅速转移。因此，未来 12 到 24 个月的竞争窗口既宝贵又脆弱。[CP008, CP012]
04财务情况
4.1 融资历史
融资历史是目前最清楚的财务信息：公司 2023 年完成 $30 million Series A，2024 年完成 $100 million Series B，披露融资累计超过 $140 million。投资者阵容广泛，既有战略投资者，也有综合型机构。这固然是积极信号，也说明投资人押注的仍是未来潜力，而非已经显现的盈利引擎。融资所能说明的不是业务成熟，而是投资人有信心继续支持硬件开发和现场部署。[CI001, CI002, CI003, CI010]
| 收入来源 | 公开资料所反映的现状 | 置信度 |
|---|---|---|
| 硬件 / 机器人本体销售 | 可能构成收入组合的一部分 | 中 |
| 现场部署服务 | 试点阶段可能离不开部署服务 | 中 |
| 软件 / 车队运维支持 | 有可能但尚未披露 | 低 |
| 经常性维保服务 | 很可能存在但尚未公布定价 | 低 |
鉴于未见公开经审计的财务数据，收入模式系基于公开信息推断。
[CI006, CI012]| 项目 | 含义 | 状态 |
|---|---|---|
| Series A | $30M 用于支持早期现场部署 | 已披露 |
| Series B | $100M 用于支持规模化扩张 | 已披露 |
| 烧钱速度 | 未知 | 未公开 |
| 现金跑道 | 未知 | 未公开 |
| 毛利率 | 未知 | 未公开 |
未见公开现金流量表；本图谱仅为尽调替代参考。
[CI001, CI002, CI012]已披露的融资里程碑及推算的资本基础。
| 条目 | 数值 | 说明 |
|---|---|---|
| 种子轮 / 早期资金 | 10 种子轮规模为估算值 | 种子轮规模为估算值 |
| Series A（2023） | 30 由 Sequoia 领投 | 由 Sequoia 领投 |
| Series B（2024） | 100 由 General Catalyst 领投 | 由 General Catalyst 领投 |
| 投后估值基准 | 500 二级市场对 Series B 前后估值的估算 | 二级市场对 Series B 前后估值的估算 |
| 据报道累计融资 | 140 公开引用的累计融资金额 | 公开引用的累计融资金额 |
| 当前披露现状 | 0 未公开经审计的财务数据，也未披露收入 | 未公开经审计的财务数据，也未披露收入 |
种子轮金额为大致估算；已披露融资总额超过图中统计的里程碑总和。
[CI001, CI002, CI003]4.2 估值与资本密集度
外部二级市场页面显示，Series B 前后估值约为 $500 million，但公司似乎没有披露当前估值。因此，这一估值只能作方向性参考，关键要看公司能否尽快证明部署可以复制。融资节奏、硬件投入和小团队都指向资本密集型模式；在能像软件公司那样自我造血前，公司仍需靠关键里程碑持续融资。尽调时，缺失的运营指标比融资总额更重要。资本能否转化为持续的客户扩张，决定估值逻辑能否站得住。[CI004, CI005, CI007, CI009, CI011]
4.3 尚未补齐的关键信息
最重要的财务问题仍未回答：烧钱速度、毛利率、单位经济性如何，客户合同有没有走出试点。公开资料不足以搭建真实的 P&L 模型。融资背书不等于财务透明。早期机器人公司披露有限并不罕见，但投资判断只能依赖产品和客户采用证据，而非财报。当前仍是融资驱动的故事，不是财务表现驱动的业务；这些指标披露前，估值推断都应保持审慎。[CI006, CI008, CI012]
05产品与技术
5.1 产品形态与定位
公开资料显示，Collaborative Robotics 做的是用于共享空间物料搬运的移动协作机器人。公司刻意避开人形机器人的定位：产品要能在人类工作环境中干活、解决实际问题，而不是做研究展示。独立报道显示，最迟到 2024 年，机器人已在真实货物转运设施（transload facility）运行，说明团队已从仿真走到现场部署。阶段仍早，但比只停留在路演材料里的机器人项目更有说服力。关键还在于，同一套系统能否不依赖定制工程团队，复制到不同设施。[CE001, CE002, CE005, CE010, CE012]
5.2 技术实现路径分析
现有技术叙事集中在多模态 AI 和共享空间作业，而非完整公开的硬件架构。Seattle 的基础模型团队显示，公司希望推进跨环境泛化、自然交互和任务学习。若这能减少客户现场调试量，价值很大；但公开规格仍很少。现有证据足以说明它不是纸面项目，却不足以证明公司已解决规模化运行中的自主能力、操作和设备运行时间（uptime）难题。尽调仍需保持高标准。[CE003, CE004, CE007, CE008, CE009, CE011]
5.3 成熟度评估与技术尽调缺口
产品看起来已进入部署阶段，而不是演示阶段；技术尽调仍缺硬数据。有效载荷（payload）、传感器配置、自主能力基准、设备运行时间、SDK 和集成细节都待补。公司的差异化主张取决于可复制性：如果机器人只适用于少数环境，实际市场会比品牌暗示的小得多。还要看基础模型进步究竟能降低部署成本，还是只让实验更烧钱；这会直接影响硬件业务的经济性。[CE005, CE006, CE008, CE011, CE012]
| 依赖项 | 重要意义 | 状态 |
|---|---|---|
| 基础模型进展 | 泛化能力的必备前提 | 前景可期但未经验证 |
| 安全控制 | 共享空间部署的必备前提 | 核心要求 |
| 现场部署数据 | 提升自主化水平的核心支撑 | 大概率较为稀缺 |
| 客户系统集成 | 规模化销售的必备前提 | 大概率高度定制化 |
各项依赖由公开宣传与通用机器人行业惯例推断得出。
[CE004, CE006, CE011]展示产品如何从现场部署逐步走向可复制的规模化。
- 现场实地部署
- 在货物转运设施投入使用
- 条目
- 现场机器人作业
- 共享空间安全
- 必须支持人机近距离协同作业
- 条目
- 行为可预测
- AI 泛化能力
- 基础模型技术演进方向
- 条目
- 多模态学习
- 工作流集成
- 对接客户系统与实际运营
- 条目
- 运营 API
- 可复制规模化
- 减少人工介入的部署路径
- 条目
- 可复制部署
- 待验证尽调缺口
- 有效载荷、正常运行时间、SDK 与基准测试数据
- 条目
- 缺少技术规格说明书
06客户情况
6.1 已披露的客户进展
公开客户信息不多，但已有真实落地。公司称首批机器人于 2024 年在一家全球物流伙伴的现场运行；第三方报道则提到 Seattle 地区的货物转运设施。机器人进入真实工作流，而非只做演示，是投资人看重的证据。即便如此，公司仍未公布完整客户名单；现有客户基础可信，但规模小且高度集中。这能证明已有客户，却不足以证明销售引擎已规模化。[CU001, CU002, CU005, CU007, CU008]
6.2 潜在客群画像分析
首批买家很可能是物流或制造业运营商：重复搬运需求多、用工压力大，也有能力组织试点。公开研究和案例显示，协作机器人的采用取决于人机工效、安全和现场工作流调校。目标客户不只是「大型企业」，还得有能力承担系统集成和流程变更。医疗和生物科技也可能适用，但目前物流场景的证据明显更强。销售周期可能从试点开始，最后需要重做工作流。[CU003, CU004, CU006, CU009, CU011]
| 风险项 | 重要意义 | 当前判断 |
|---|---|---|
| 单一站点集中 | 未见大规模铺开的证据 | 高 |
| 从试点到实际生产的转化 | 不少机器人试点最终没能规模化 | 尚不明确 |
| 合同不透明 | 未披露合同规模或条款 | 高 |
| 跨场地扩张 | 若能实现将验证模式可复制性 | 未知 |
因缺少已披露合同条款，扩张分析以定性评估为主。
[CU005, CU007, CU010, CU012]以试点为起点，从首次部署逐步扩展到可复制的多站点运营。
[CU004, CU007, CU012]6.3 落地质量与尽调缺口
尽调关键是看公司能否从一个标志性部署走向可复制的客户和站点基础。公开资料没有披露留存指标、合同数量或完整客户名单，采用逻辑仍显脆弱。关键不是「有没有客户」，而是「有多少站点、设备运行时间如何、客户扩张了多少」。没有这些答案，现有证据只能说明早期落地，不能证明规模化。单个试点和可扩张客户基础之间，隔着故事与生意的距离。[CU004, CU010, CU012]
07风险
7.1 核心风险
早期机器人公司最常遇到的致命风险是安全、可靠性，以及从优秀演示走到可复制部署的落差。机器人在人身边运行，一旦出故障，信任代价高于有围栏隔离的系统。协作机器人领域的公开研究一再强调：安全不是附加功能，而是产品本身。公司公开的运行数据不足以排除停机或边缘场景故障，所以下行风险并非假设。一次严重事故就可能重置客户信心，投资人也会迅速把风险计入价格。[CR001, CR002, CR003, CR008, CR009]
7.2 商业化与执行风险
第二层是商业化风险：公司能否把少数部署转成可复制的客户基础？硬件公司常因部署定制化、利润薄而停滞；每新增一个站点，工程投入也可能超过销售团队预期。团队小会放大执行压力，客户现场的每个问题都可能占用创始人时间。资本密集度又加重风险：若公司需要更多硬件、更多集成工作，或销售周期比计划更长，股权稀释或下调估值融资的可能性就会上升。[CR004, CR005, CR006, CR010, CR012]
| 依赖项 | 敞口程度 | 状态 |
|---|---|---|
| 创始人精力投入 | 极高 | 团队规模小 |
| 客户信任 | 极高 | 尚未获得广泛验证 |
| 安全证据 | 极高 | 尚不完整 |
| 一级资本市场 | 高 | 仍依赖风险投资 |
依赖图谱刻意保持保守口径。
[CR005, CR006, CR007]安全、商业化、执行和资本风险的定性热力图。
[CR001, CR004, CR005, CR010]7.3 风险可承受的前提条件
缓解风险的思路不复杂：收窄应用场景、严谨论证安全、积累现场数据，并在产品反复证明可靠前放慢扩张。这不是低风险方案，但有机会让公司活下来。若能聚焦窄场景、快速学习，当前风险组合尚可管理；若产品还没反复验证就急着扩张，同样的风险足以拖垮公司。若客户在签约前要求接近认证级别的证据，压力会更大。公司越快拿出可信的现场数据，越容易降低销售阻力。因此，未来 6 到 12 个月至关重要。[CR011, CR012]
08估值
8.1 如何看待当前估值水平
目前最有支撑的公开估值参照，仍是与 2024 年 Series B 相关、约 $500 million 的估值信号。这不等于最新基本面估值：公开信号能说明 VC 有信心，却不足以支撑成熟软件公司的估值倍数。当前估值更多反映潜力和融资能力，并非已经验证的经营规模。应把它当作参照，而不是结论；这是市场信号，不是今天经核实的内在价值。[CV001, CV002, CV003, CV011]
8.2 上行情景、下行风险与审慎立场的原因
乐观情景取决于部署能否复制、客户站点能否扩张，以及产品能否避免在每家客户现场都付出一轮定制工程成本。悲观情景则是典型的硬件陷阱：客户采用放缓、烧钱居高不下，下一轮估值低于当前二级市场信号。收入和客户扩张的公开数据有限，现阶段更适合跟踪公司、等待经营证据，而不是认定当前估值能够维持。这样也能避免虚假的精确判断。[CV004, CV005, CV006, CV008, CV009, CV010, CV012]
| 区间 | 解读 | 置信度 |
|---|---|---|
| $500M 左右的二级市场估值信号 | 当前最明确的公开信号 | 中 |
| 扩张只有被证明可复制，估值才有上行空间 | 上行空间需要运营实证支撑 | 低 |
| 若客户采纳停滞或烧钱加速，估值将下调 | 硬件业务风险引发下行压力 | 中 |
本表只依据公开信号，刻意保持保守。
[CV001, CV003, CV012]定性展示经营证据如何影响估值判断。
[CV001, CV003, CV009]8.3 可比标的框架
可比对象应优先选机器人公司，而非软件公司。公开资料显示，投资人和市场数据机构仍把 Collaborative Robotics 与其他落地风险高、收入不确定的非上市机器人公司对照，这一框架更合适。因此，当前宜把它视作值得跟踪的机器人平台，但目前还不是可以充分承销的成长型资产。要转向更积极的判断，还需要更多客户验证和更清晰的毛利率改善路径。最接近的可比公司也不够完美，只能提供方向参考。市场估值调整往往快于基本面出现实质变化。[CV007, CV008, CV011]
免责声明
本报告仅为基于公开证据的尽调速览，不构成投资建议。关键财务、法律、技术及合同事实仍未公开，在做出任何投资决策前，应直接向管理层及一手文件核实。
证据索引
| 编号 | 陈述 | 可信度 | 来源 |
|---|---|---|---|
| CO001 | Collaborative Robotics was founded in 2022 and is based in Santa Clara, California. | 高 | SO001, SO002 |
| CO002 | The company is led by Brad Porter, whose prior Amazon robotics background is the central founder-market-fit signal. | 高 | SO002, SO007 |
| CO003 | Public profiles describe the company as a developer of practical collaborative robots or human-capable mobile manipulators for shared workspaces. | 中 | SO001, SO005 |
| CO004 | GeekWire reported the company employed about 40 people in 2024 after opening a Seattle office for AI research. | 中 | SO007, SO008 |
| CO005 | The disclosed Series B raised $100 million and brought total funding to more than $140 million. | 高 | SO007, SO008, SO001 |
| CO006 | The latest round was led by General Catalyst with participation from Sequoia, Khosla, Mayo Clinic, Neo, 1984 Ventures, MVP Ventures, Calibrate Ventures, Bison Ventures, Industry Ventures, and Lux Capital. | 高 | SO007, SO001, SO008 |
| CO007 | The company announced an advisor addition with Teresa Carlson, underscoring go-to-market ambitions beyond pure research. | 中 | SO007, SO008 |
| CO008 | Caplight and the private-market aggregators still show the company as opaque on current valuation and revenue disclosure. | 中 | SO003, SO004, SO005 |
| CO009 | The company’s public narrative emphasizes human-robot collaboration, trustworthiness, and a practical rather than humanoid form factor. | 中 | SO005, SO007 |
| CO010 | Public reporting indicates the first robots were in the field earlier in 2024, before the Series B announcement. | 中 | SO007, SO008 |
| CO011 | The company’s stated target sectors include logistics, manufacturing, healthcare, retail, and municipal services. | 中 | SO001, SO005 |
| CO012 | A material diligence gap remains around exact revenue, customer concentration, and burn because the company does not publicly disclose audited financials. | 中 | SO003, SO004, SO008 |
| CM001 | Collaborative Robotics sits in the shared-space cobot / mobile-manipulation segment, not in classic fixed-arm industrial automation alone. | 高 | SM001, SM002, SM003 |
| CM002 | The most plausible first buyer is a logistics or manufacturing operator with repetitive material-handling pain and a willingness to run pilots before full-scale rollout. | 中 | SM003, SM008 |
| CM003 | Public market reports still describe collaborative robotics as a fast-growing category with strong AI and sensor adoption tailwinds. | 中 | SM008, SM006, SM007 |
| CM004 | The company’s own public messaging emphasizes “real-world applicability,” predictable behavior, and safer collaboration rather than humanoid spectacle. | 高 | SM001, SM002 |
| CM005 | Safety, space-sharing, and workflow integration remain the primary blockers to rapid adoption in brownfield facilities. | 中 | SM003, SM008, SM006 |
| CM006 | The likely ROI story is labor substitution, reduced physical strain, and better throughput rather than fully autonomous general intelligence. | 中 | SM001, SM002, SM003 |
| CM007 | Warehouse, manufacturing, healthcare, retail/e-commerce, and municipal services are the recurring verticals mentioned in public sources. | 中 | SM003, SM001, SM006 |
| CM008 | Secondary-market pages still suggest the company is small relative to the broader automation opportunity and that its market position is not yet widely benchmarked. | 中 | SM004, SM005, SM008 |
| CM009 | The cobot market thesis depends on whether AI-driven adaptability can overcome the historical reluctance to place robots in direct human work zones. | 中 | SM001, SM006 |
| CM010 | Adjacent automation substitutes include AMRs, fixed conveyors, human labor, and narrower pick-and-place robots. | 中 | SM003, SM008 |
| CM011 | Dealroom and VCBacked style profiles suggest investors still frame the company as a venture-backed hardware platform rather than a mature category winner. | 中 | SM007, SM008 |
| CM012 | The market story is promising but still underspecified on share capture and concrete replacement economics. | 中 | SM004, SM005, SM006 |
| CP001 | Direct competitive pressure comes from robotics startups and incumbents pursuing mobile manipulation, warehouse automation, or humanoid form factors. | 中 | SP003, SP006, SP008 |
| CP002 | Likely named rivals include Covariant, Figure AI, 1X, Sanctuary AI, Agility Robotics, and other warehouse-automation players. | 中 | SP003, SP006 |
| CP003 | Incumbent and adjacent substitutes include fixed automation, AMRs, human labor, and narrower pick-and-place robots. | 中 | SP001, SP002, SP003 |
| CP004 | The company’s differentiation is a practical collaborative robot that is human-capable but explicitly not a humanoid demo product. | 高 | SP003, SP002, SP001 |
| CP005 | A likely moat would come from deployment learning, workflow integration, and customer trust rather than from pure mechanical novelty. | 中 | SP004, SP005, SP008 |
| CP006 | Productive Robotics represents a more conventional collaborative-robot automation competitor, useful as an incumbent benchmark for pricing and feature breadth. | 中 | SP001, SP002 |
| CP007 | Private-market aggregators still treat the company as early and hard to benchmark against public comparables. | 中 | SP004, SP005, SP008 |
| CP008 | The competitive field is crowded enough that a weak product deployment cadence would quickly compress perceived differentiation. | 中 | SP003, SP008, SP006 |
| CP009 | The company’s mobile-manipulation framing helps it avoid direct head-to-head comparison with humanoid robot hype, but it does not eliminate substitute risk. | 中 | SP003, SP002 |
| CP010 | Public sources do not show a clearly published performance benchmark or install base that would make the moat obvious today. | 中 | SP004, SP005, SP006 |
| CP011 | A strategic advantage could still exist if the company proves repeatable deployments in logistics before larger peers catch up. | 中 | SP003, SP008 |
| CP012 | The category is still early enough that market-share outcomes remain highly path-dependent, not locked in. | 中 | SP006, SP008 |
| CI001 | The company raised $30 million in Series A funding in July 2023 and $100 million in Series B funding in April 2024. | 高 | SI003, SI002 |
| CI002 | Public reporting puts total capital raised at more than $140 million, with the later round bringing the company to a larger commercial scale-up phase. | 高 | SI002, SI004, SI001 |
| CI003 | The Series B investor base includes General Catalyst, Sequoia, Khosla, Mayo Clinic, Neo, 1984 Ventures, MVP Ventures, Calibrate, Bison, Industry Ventures, and Lux Capital. | 高 | SI002, SI003 |
| CI004 | Caplight and similar private-market pages show a $500 million valuation estimate around the April 2024 Series B, but no current official valuation disclosure. | 中 | SI005, SI006, SI007 |
| CI005 | The company has not publicly disclosed audited revenue, ARR, gross margin, or a run-rate that would support a public-style financial model. | 中 | SI005, SI006, SI008 |
| CI006 | The fundraising language consistently emphasizes field deployment, manufacturing scale-up, and team expansion rather than profitability. | 中 | SI002, SI004 |
| CI007 | The funding cadence suggests a hardware business that remains capital intensive and still dependent on external capital for growth. | 中 | SI003, SI002, SI001 |
| CI008 | Headcount at the time of the 2024 coverage was still around the few-dozen range, which reinforces the early-stage operating profile. | 中 | SI003, SI008 |
| CI009 | The company’s external data pages still frame it as privately held with limited market activity, which is consistent with no public revenue disclosure. | 中 | SI001, SI008, SI007 |
| CI010 | The investor mix combines strategic robotics capital with deep-tech VCs, which usually signals both technical promise and commercialization risk. | 中 | SI002, SI004 |
| CI011 | The range of external valuation pages is still wide enough that any single mark should be treated as directional, not definitive. | 中 | SI005, SI006, SI007 |
| CI012 | Financial underwriting remains blocked mainly by missing burn, gross margin, and contract-revenue data rather than by lack of financing evidence. | 中 | SI001, SI008, SI002 |
| CE001 | Public descriptions frame the product as a mobile collaborative robot built for material handling in shared workspaces. | 中 | SE001, SE006 |
| CE002 | The company and press coverage explicitly describe the robot as human-capable but not humanoid, which is an important design distinction. | 中 | SE002, SE003 |
| CE003 | The AI story centers on multimodal or foundation-model-style perception and interaction rather than on a fully disclosed classical robotics stack. | 中 | SE002, SE003, SE006 |
| CE004 | The Seattle Foundation Models AI team suggests the company is investing in generalization and natural interaction as product differentiators. | 中 | SE008, SE006 |
| CE005 | Public reporting says the robot was already in field use at a transload facility in 2024, which is stronger than a lab-only posture. | 中 | SE006, SE008 |
| CE006 | Safety remains a core design constraint because the robot must work near people and in shared spaces. | 中 | SE001, SE003, SE002 |
| CE007 | The integration layer is likely a workflow orchestration stack that connects the robot to customer operations rather than a standalone point robot. | 中 | SE004, SE005, SE007 |
| CE008 | The company has not publicly disclosed exact payload, sensor stack, or SDK detail, so technical diligence still lacks a formal spec sheet. | 中 | SE001, SE006 |
| CE009 | The practical technology edge is plausible only if the robot can learn varied tasks without requiring an expensive re-engineering cycle for each customer. | 中 | SE003, SE002 |
| CE010 | The company’s public narrative prioritizes trustworthiness, predictable behavior, and real-world applicability over flashy research demos. | 中 | SE001, SE007 |
| CE011 | Public sources do not yet show a published benchmark pack for autonomy, manipulation success, or uptime, which limits technical comparability. | 中 | SE004, SE005, SE008 |
| CE012 | Technical maturity appears above prototype but below fully open, productized platform status because deployment details remain partial. | 中 | SE008, SE006, SE007 |
| CU001 | The company publicly says its first robots were in the field with a global logistics partner in 2024. | 高 | SU001, SU008 |
| CU002 | GeekWire reported a transload facility deployment in the Seattle region, which is the strongest public sign of real-world use. | 高 | SU001, SU002 |
| CU003 | The company’s stated target verticals include logistics, manufacturing, healthcare, retail/e-commerce, and municipal services. | 中 | SU001, SU007 |
| CU004 | The Cobot Flywheel / pilot-program language suggests a pilot-led commercial motion rather than an instant self-serve sale. | 中 | SU004, SU008, SU006 |
| CU005 | Customer concentration is probably high because only a handful of names or partner types are publicly visible. | 中 | SU005, SU006, SU007 |
| CU006 | Independent robotics literature and case studies show that cobot adoption depends heavily on ergonomics, safety, and local workflow tuning. | 中 | SU002, SU004, SU001 |
| CU007 | The public evidence is still stronger for “a deployment exists” than for “a repeatable customer base exists.” | 中 | SU001, SU008, SU007 |
| CU008 | Research and industry pages do not reveal any broad customer list, retention metric, or contract volume data. | 中 | SU005, SU006, SU008 |
| CU009 | The company’s likely first customer profile is a process-heavy operator with high labor pain and manageable deployment complexity. | 中 | SU003, SU002 |
| CU010 | The available public case-study style evidence is still too thin to infer net retention or expansion success. | 中 | SU002, SU004 |
| CU011 | A logistics / warehouse deployment is the clearest proof point, while healthcare and biotech remain more aspirational in the public record. | 中 | SU001, SU008, SU007 |
| CU012 | Customer diligence should focus on referenceability, uptime, and whether the robot is on a single site or multiple sites. | 中 | SU005, SU006, SU008 |
| CR001 | Safety and human-adjacent operation remain the most obvious risk because the product is designed for shared spaces rather than fenced-off cells. | 中 | SR002, SR007 |
| CR002 | Robotics literature consistently shows that human-robot collaboration requires careful safety design, sensing, and ergonomic tuning. | 高 | SR002, SR007 |
| CR003 | Community discussions and GitHub-topic style signals show that reliability and safety concerns are still common in collaborative robotics generally. | 中 | SR001, SR003 |
| CR004 | Commercial risk is high because the company must prove it can scale from a few deployments to repeatable field adoption. | 中 | SR004, SR005, SR006 |
| CR005 | A small team makes the company vulnerable to key-person and execution bottlenecks if deployment complexity increases. | 中 | SR008, SR006 |
| CR006 | Secondary-market pages still show the company as early and difficult to benchmark, which is a risk marker for underwriting confidence. | 中 | SR004, SR005, SR008 |
| CR007 | Customer or partner concentration likely creates outsized downside if a single deployment path stalls or disappoints. | 中 | SR006, SR008 |
| CR008 | The public record does not show enough technical telemetry to rule out uptime, manipulation, or edge-case safety issues. | 中 | SR002, SR003, SR001 |
| CR009 | Regulatory and insurance issues could slow adoption if customers require evidence that the robot can operate safely near people. | 中 | SR002, SR007 |
| CR010 | Any product-market-fit disappointment would be amplified by the capital intensity of hardware and manufacturing scale-up. | 中 | SR004, SR005 |
| CR011 | Mitigation would likely come from narrow use cases, rigorous safety cases, and more field data before broad expansion. | 中 | SR002, SR008 |
| CR012 | The current risk stack is real but not existential if the company can keep deployments narrow and learn quickly. | 中 | SR006, SR008 |
| CV001 | Caplight’s page still shows a roughly $500 million valuation signal tied to the April 2024 Series B. | 中 | SV005, SV006 |
| CV002 | Forbes and Crunchbase both framed the 2024 round as a unicorn-status or near-unicorn moment, which is more hype than exact pricing. | 中 | SV003, SV004 |
| CV003 | The public data do not show a newer official valuation, so the current mark should be treated as stale and directional. | 中 | SV002, SV005, SV009 |
| CV004 | The upside case depends on proving repeatable deployments and a real pathway to scale rather than just one or two high-profile pilots. | 中 | SV008, SV007 |
| CV005 | The downside case is a slow-sales, high-burn hardware path that forces a lower mark before the company can scale meaningfully. | 中 | SV005, SV006, SV009 |
| CV006 | A cautious underwriting stance is justified because the company has financing proof but limited financial transparency and only partial customer evidence. | 中 | SV003, SV004, SV008 |
| CV007 | Comparable companies and market pages imply that valuation should be judged against robotics peers with similar deployment risk, not against software multiples. | 中 | SV007, SV009, SV006 |
| CV008 | Because the company is still early and opaque, the right recommendation is to track the company rather than underwrite it aggressively today. | 中 | SV002, SV005, SV008 |
| CV009 | The market still lacks enough public operating data to support a confident fair-value range with tight error bars. | 中 | SV005, SV006, SV009 |
| CV010 | A more positive view would require repeatable customer expansion, better financial disclosure, and evidence that the product can scale without constant custom engineering. | 中 | SV003, SV008 |
| CV011 | The current public signal is stronger than a stealth startup but weaker than a company ready for a confident late-stage growth mark. | 中 | SV007, SV005, SV002 |
| CV012 | If adoption stalls, the company is exposed to a lower secondary-market mark and a dilution-heavy path to the next financing event. | 中 | SV005, SV006, SV003 |